Thursday, January 07, 2021 12:26:20 PM
HOPEWELL JUNCTION, NY / ACCESSWIRE / January 7, 2021 / eMagin Corporation (NYSE American:EMAN), a leader in the development, design and manufacture of Active Matrix OLED microdisplays used in Military and Commercial AR/VR devices, and other near-eye imaging products, today announced that CEO Andrew Sculley and Acting CFO Mark Koch will be presenting at the 23rd Annual Needham Growth Conference on Thursday, January 14th, at 11:30 AM EST in Track 4. Members of eMagin management will also be available for one-on-one meetings on Wednesday, January 13th and the morning of Thursday, January 14th.
To listen to the webcast, interested parties should use the following link:
https://wsw.com/webcast/needham103/eman/2221254
An archived version of the presentation will be available for ninety days on the Company's website in the investor section under webcasts and/or events.
About eMagin
The leader in OLED microdisplay technology for the next generation of computing and imaging devices, serving world-class customers in the military, consumer, medical and industrial markets. We invent, engineer and manufacture display technologies of the future in the USA, including our Direct Patterning Technology (dPd) that will transform the way the world consumes information. Since 2001, our microdisplays have been, and continue to be, used in AR/VR, aircraft helmets, heads-up display systems, thermal scopes, night vision goggles, future weapon systems and a variety of other applications. www.emagin.com
Contact:
eMagin Corporation
Mark A. Koch, Acting Chief Financial Officer
845-838-7951
mkoch@emagin.com
Affinity Growth Advisors
Betsy Brod
212-661-2231
betsy.brod@affinitygrowth.com
SOURCE: eMagin Corporation
Recent EMAN News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/30/2023 12:30:06 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/30/2023 04:15:21 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/27/2023 12:36:43 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/27/2023 12:33:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/27/2023 12:32:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM